135 related articles for article (PubMed ID: 12832077)
1. Molecular mechanism for the enhancement of arbekacin resistance in a methicillin-resistant Staphylococcus aureus.
Matsuo H; Kobayashi M; Kumagai T; Kuwabara M; Sugiyama M
FEBS Lett; 2003 Jul; 546(2-3):401-6. PubMed ID: 12832077
[TBL] [Abstract][Full Text] [Related]
2. [Arbekacin resistant gene, aacA/aphD, in Staphylococcus aureus is lost during in vitro passage].
Chen G; Fukuchi K; Wakuta R; Kubo S; Yasuhara T; Takagi Y; Gomi K
Rinsho Byori; 2002 Jan; 50(1):79-84. PubMed ID: 11871141
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. IV. Aminoglycoside-modifying enzyme AAC(6')/APH(2") is responsible for arbekacin-resistance enhanced by bleomycin.
Inouye Y; Hashimoto M; Sugiyama M; Takesue Y; Santo T; Yokoyama T
Hiroshima J Med Sci; 1994 Sep; 43(3):87-92. PubMed ID: 7534753
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)].
Tabata M; Shimizu M; Araake M; Ogawa H
Jpn J Antibiot; 2003 Feb; 56(1):36-43. PubMed ID: 12723397
[TBL] [Abstract][Full Text] [Related]
5. [Necessity and usefulness of detection by PCR of mecA and aac(6')/aph(2") genes for identification of arbekacin-resistant MRSA].
Hotta K; Ishikawa J; Ishii R; Saitoh F; Kira K; Arakawa Y; Ike Y
Jpn J Antibiot; 1999 Aug; 52(8):525-32. PubMed ID: 10587877
[TBL] [Abstract][Full Text] [Related]
6. [Emergence of arbekacin resistant strains among methicillin-resistant Staphylococcus aureus].
Suzuki T; Fujita K; Nagamachi Y; Okubo T
Jpn J Antibiot; 1994 Jun; 47(6):634-9. PubMed ID: 8072171
[TBL] [Abstract][Full Text] [Related]
7. Specificity of 4'''-acetylation by an aminoglycoside-modifying enzyme in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus.
Fujimura S; Tokue Y; Takahashi H; Nukiwa T; Watanabe A
Tohoku J Exp Med; 1998 Sep; 186(1):67-70. PubMed ID: 9915109
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a bifunctional aminoglycoside-modifying enzyme with novel substrate specificity and its gene from a clinical isolate of methicillin-resistant Staphylococcus aureus with high arbekacin resistance.
Ishino K; Ishikawa J; Ikeda Y; Hotta K
J Antibiot (Tokyo); 2004 Oct; 57(10):679-86. PubMed ID: 15638329
[TBL] [Abstract][Full Text] [Related]
9. Novel arbekacin- and amikacin-modifying enzyme of methicillin-resistant Staphylococcus aureus.
Fujimura S; Tokue Y; Takahashi H; Kobayashi T; Gomi K; Abe T; Nukiwa T; Watanabe A
FEMS Microbiol Lett; 2000 Sep; 190(2):299-303. PubMed ID: 11034295
[TBL] [Abstract][Full Text] [Related]
10. Trends of arbekacin-resistant MRSA strains in Japanese hospitals (1979 to 2000).
Tsuchizaki N; Ishino K; Saito F; Ishikawa J; Nakajima M; Hotta K
J Antibiot (Tokyo); 2006 Apr; 59(4):229-33. PubMed ID: 16830890
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus.
Inoue M; Nonoyama M; Okamoto R; Ida T
Drugs Exp Clin Res; 1994; 20(6):233-9. PubMed ID: 7758395
[TBL] [Abstract][Full Text] [Related]
12. [Development of arbekacin and synthesis of new derivatives stable to enzymatic modifications by methicillin-resistant Staphylococcus aureus].
Kondo S
Jpn J Antibiot; 1994 Jun; 47(6):561-74. PubMed ID: 8072163
[TBL] [Abstract][Full Text] [Related]
13. [Susceptibility of methicillin-resistant Staphylococcus aureus to various antibiotics. Classification by aminoglycoside-modifying enzymes and antibiotics active against MRSA].
Kondo S; Ikeda Y; Hattori S; Hamada M; Takeuchi T
Jpn J Antibiot; 1991 Nov; 44(11):1211-5. PubMed ID: 1664469
[TBL] [Abstract][Full Text] [Related]
14. [Genomic DNA fingerprinting of arbekacin-resistant MRSA by pulsed-field gel electrophoresis].
Nonoyama M; Ida T; Hasobe T; Shimauchi C; Inoue M; Okamoto R; Okubo T
Jpn J Antibiot; 1994 Jun; 47(6):627-33. PubMed ID: 8072170
[TBL] [Abstract][Full Text] [Related]
15. Structures of enzymatically modified products of arbekacin by methicillin-resistant. Staphylococcus aureus.
Kondo S; Tamura A; Gomi S; Ikeda Y; Takeuchi T; Mitsuhashi S
J Antibiot (Tokyo); 1993 Feb; 46(2):310-5. PubMed ID: 8468247
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus.
You I; Kariyama R; Zervos MJ; Kumon H; Chow JW
Diagn Microbiol Infect Dis; 2000 Jan; 36(1):37-41. PubMed ID: 10744365
[TBL] [Abstract][Full Text] [Related]
17. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
[TBL] [Abstract][Full Text] [Related]
18. [Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus].
Deguchi K; Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Matsumoto Y; Nishinari C; Nakane Y; Fukumoto T
Jpn J Antibiot; 1997 Jan; 50(1):1-11. PubMed ID: 9059909
[TBL] [Abstract][Full Text] [Related]
19. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. III. Combined effects of arbekacin with cefotiam or cefuzonam].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1992 Oct; 45(10):1305-11. PubMed ID: 1479682
[TBL] [Abstract][Full Text] [Related]
20. Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes.
Barada K; Hanaki H; Ikeda S; Yamaguchi Y; Akama H; Nakae T; Inamatsu T; Sunakawa K
J Infect Chemother; 2007 Apr; 13(2):74-8. PubMed ID: 17458673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]